Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection (Q92392250)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection |
clinical trial |
Statements
Coronavirus (English)
0 references
A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients With Severe COVID-19 Infection (English)
0 references
17 April 2020
0 references
31 August 2020
0 references
230
0 references
18 year
0 references